Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081714/
https://www.ncbi.nlm.nih.gov/pubmed/32214829
http://dx.doi.org/10.2147/JAA.S251079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081714/
https://www.ncbi.nlm.nih.gov/pubmed/32214829
http://dx.doi.org/10.2147/JAA.S251079

Ejemplares similares